Learn the typical research dosage for CJC 1295 no DAC, how it compares with DAC versions, and why human use remains unapproved in the United States.
CJC-1295 no DAC does not have an FDA-approved human dosage. In research settings and online discussions, amounts commonly mentioned range from 100 mcg to 300 mcg per injection, often once or twice daily, but no standard human dose has been established. Anyone considering this peptide should speak with a licensed healthcare professional first.
What CJC-1295 No DAC Is and Why Dosage Is Unclear
CJC-1295 no DAC is a synthetic analog of growth hormone-releasing hormone (GHRH). It is also called modified GRF(1-29) or Mod GRF 1-29. The "no DAC" version lacks the drug affinity complex that extends half-life, so it clears the body much faster than CJC-1295 with DAC.
Because the peptide is not approved for human use, there are no official dosing guidelines. Published human data are limited, and most dosage information comes from animal studies, research forums, and personal reports rather than controlled clinical trials.
CJC-1295 no DAC is sold as a research chemical in the United States. The FDA has not approved it for treating any medical condition, including weight loss or hormone deficiency.
Commonly Discussed Research Amounts
Many online guides describe a cjc-1295 no dac dosage of 100 mcg to 300 mcg per injection. Frequency usually ranges from once daily to twice daily, with injections often timed around fasting or sleep. These numbers are anecdotal and should not be treated as medical advice.
| Commonly cited amount | Frequency | Typical timing | Notes |
|---|---|---|---|
| 100 mcg | Once or twice daily | Before bed or morning | Lower end of forum reports |
| 200 mcg | Once or twice daily | Fasted state | Middle range in discussions |
| 300 mcg | Once daily | Before sleep | Upper end of common anecdotes |
No human trial has confirmed that any of these amounts are safe or effective. Individual responses can vary widely based on age, health status, and other factors.
CJC-1295 No DAC vs CJC-1295 DAC
The main difference between the two versions is half-life. CJC-1295 no DAC lasts roughly 30 minutes in the body, while CJC-1295 with DAC can last several days. That difference changes how often each peptide is discussed for research use.
| Feature | CJC-1295 no DAC | CJC-1295 with DAC |
|---|---|---|
| Half-life | About 30 minutes | About 6 to 8 days |
| Commonly cited frequency | Once or twice daily | Once weekly |
| Commonly cited amount | 100 to 300 mcg per injection | 1 to 2 mg per week |
| FDA status | Not approved for human use | Not approved for human use |
People who ask about cjc 1295 dac dosage for weight loss usually encounter weekly amounts of 1 mg to 2 mg, though weight loss is not an approved use. Studies on body composition changes in humans are lacking for both versions.
CJC-1295 No DAC and Ipamorelin Blends
CJC-1295 no DAC is often combined with ipamorelin, a growth hormone secretagogue. A popular product is a 10 mg blend that contains 5 mg of each peptide. The cjc-1295 no dac ipamorelin 10mg blend dosage most often discussed is 100 mcg of each peptide per injection, once or twice daily.
Blending two research chemicals does not make either one approved for human use. The safety profile of the combination is not well studied in controlled human trials.
- Typical blend ratio: 1:1 (5 mg CJC-1295 no DAC + 5 mg ipamorelin)
- Commonly cited draw: 100 mcg of each peptide
- Frequency in forum reports: once or twice daily
- Approval status: not FDA-approved for human use
Understanding a CJC-1295 No DAC Dosage Chart
A cjc-1295 no dac dosage chart usually converts milligrams of powder and milliliters of bacteriostatic water into micrograms per syringe unit. The math matters because a small error can lead to a much larger or smaller amount than intended.
| Vial size | Water added | Concentration | 100 mcg draw (U-100 syringe) |
|---|---|---|---|
| 2 mg | 2 mL | 1 mg/mL | 10 units |
| 2 mg | 1 mL | 2 mg/mL | 5 units |
| 5 mg | 2.5 mL | 2 mg/mL | 5 units |
Always double-check calculations and use sterile technique if handling research chemicals. Never assume that a chart found online is accurate for your specific vial or syringe.
Safety, Legality, and Sourcing
CJC-1295 no DAC is not approved by the FDA for human use in the United States. It is sold as a research chemical, which means it is intended for laboratory study only. Because cjc 1295 no dac for sale listings often describe the product as a research chemical, the label legally cannot provide human dosing instructions.
Reported side effects from anecdotal use include injection site reactions, headaches, water retention, and changes in blood sugar. Long-term safety data in humans do not exist. People with hormone-sensitive conditions, diabetes, or cancer should be especially cautious.
No one should use CJC-1295 no DAC without first consulting a licensed healthcare professional. Self-dosing with research peptides carries unknown risks.
Laws vary by country and state. In the US, possession of research chemicals is generally legal for laboratory use, but human consumption is not approved. Buying from unregulated vendors also raises concerns about purity and contamination.
Key Takeaways
- CJC-1295 no DAC has no FDA-approved human dosage.
- Online discussions commonly cite 100 mcg to 300 mcg once or twice daily, but these amounts are anecdotal.
- CJC-1295 with DAC has a much longer half-life and is typically discussed at 1 mg to 2 mg per week.
- Ipamorelin blends are often discussed at 100 mcg of each peptide per injection.
- Always consult a healthcare professional before considering any research peptide.
Frequently Asked Questions
What is the typical dosage for CJC 1295 no DAC?
There is no established human dosage. Research forums and online guides commonly mention 100 mcg to 300 mcg per injection, once or twice daily, but these amounts come from anecdotal reports, not controlled clinical trials. CJC-1295 no DAC is not FDA-approved for human use.
How does CJC 1295 no DAC dosage compare to CJC 1295 DAC dosage?
CJC-1295 no DAC has a short half-life of about 30 minutes, so it is usually discussed for once- or twice-daily injections. CJC-1295 with DAC lasts about 6 to 8 days and is commonly discussed at 1 mg to 2 mg once weekly. Neither version is approved for human use.
Is CJC 1295 no DAC safe or legal?
CJC-1295 no DAC is sold as a research chemical and is not approved by the FDA for human consumption. Its long-term safety in humans is unknown, and reported side effects include injection site reactions, headaches, and water retention. Talk to a licensed healthcare professional before using any research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.